Time-varying serum gradient of hepatitis B surface antigen predicts risk of relapses after off-NA therapy.

about

Time-varying serum gradient of hepatitis B surface antigen predicts risk of relapses after off-NA therapy.

Item

http://www.wikidata.org/entity/Q47105045

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Time-varying serum gradient of ...... relapses after off-NA therapy.

@en

Time-varying serum gradient of ...... relapses after off-NA therapy.

@nl

type

Item

label

Time-varying serum gradient of ...... relapses after off-NA therapy.

@en

Time-varying serum gradient of ...... relapses after off-NA therapy.

@nl

prefLabel

Time-varying serum gradient of ...... relapses after off-NA therapy.

@en

Time-varying serum gradient of ...... relapses after off-NA therapy.

@nl

P1476

Time-varying serum gradient of ...... relapses after off-NA therapy

@en

P2093

Chi-Ming Tai

http://www.w3.org/2001/XMLSchema#string

Chi-Yang Chang

http://www.w3.org/2001/XMLSchema#string

Chih-Wen Lin

http://www.w3.org/2001/XMLSchema#string

Chun-Ying Wu

http://www.w3.org/2001/XMLSchema#string

Jaw-Town Lin

http://www.w3.org/2001/XMLSchema#string

Lein-Ray Mo

http://www.w3.org/2001/XMLSchema#string

Ming-Shiang Wu

http://www.w3.org/2001/XMLSchema#string

Nai-Hsuan Chien

http://www.w3.org/2001/XMLSchema#string

Tzeng-Huey Yang

http://www.w3.org/2001/XMLSchema#string

Yao-Chun Hsu

http://www.w3.org/2001/XMLSchema#string

P2860

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

Chronic hepatitis B: update 2009

Epidemiology of viral hepatitis and hepatocellular carcinoma

Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study.

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update.

Recent advances in the treatment of chronic hepatitis B.

Discontinuation of oral antivirals in chronic hepatitis B: A systematic review.

Assessing the Durability of Entecavir-Treated Hepatitis B Using Quantitative HBsAg.

Association Between Serum Level of Hepatitis B Surface Antigen at End of Entecavir Therapy and Risk of Relapse in E Antigen-Negative Patients.

Association Between Level of Hepatitis B Surface Antigen and Relapse After Entecavir Therapy for Chronic Hepatitis B Virus Infection.

P2888

s12876-017-0697-3

P304

154

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12876-017-0697-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jia-Horng Kao

P577

2017-12-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1099596944

http://www.w3.org/2001/XMLSchema#string

P698

29221441

http://www.w3.org/2001/XMLSchema#string

P932

5723064

http://www.w3.org/2001/XMLSchema#string